Background Triple-negative breast cancer (TNBC) is a recurrent, heterogeneous, and invasive form of breast cancer. The treatment of TNBC patients with paclitaxel and fluorouracil in a sequential manner has shown promising outcomes.
Yuan Ma +10 more
doaj +1 more source
Selective targeting of cancer cells is a critical step in cancer diagnosis and therapy. To address this need, DNA aptamers have attracted significant attention as possible targeting ligands. However, while their use in targeting cancer cells in vitro has
Tang, Li +12 more
core +1 more source
Guojun Xu,1–3,* Xinghua Yu,2,* Jinxie Zhang,1,2,* Yingchao Sheng,4 Gan Liu,2 Wei Tao,1,2 Lin Mei1,2 1School of Life Sciences, Tsinghua University, Beijing, 2Graduate School at Shenzhen, Tsinghua University, Shenzhen, 3School of Materials Science ...
Xu GJ +6 more
doaj
Selective alkylation and bioactivity of phosphorothioated nucleolin aptamer AS1411
openaire +1 more source
Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review. [PDF]
Di Leandro L +8 more
europepmc +1 more source
Aptamer-functionalized exosomes co-delivering miR-934 inhibitor and gemcitabine for targeted pancreatic cancer therapy. [PDF]
Bi J +9 more
europepmc +1 more source
Research progress of aptamers in the diagnosis and treatment of colorectal cancer (Review). [PDF]
Li Y, Yan P, Zhang J, Wu B, Li M, Bao B.
europepmc +1 more source
Aptamer-Based Heterobifunctional Targeted Degraders in Disease Treatment. [PDF]
Liang X +5 more
europepmc +1 more source
High-Sensitivity Magnetic Particle Spectroscopy Platform for Precise, Specific, and Rapid Detection of Infectious Disease and Cancer-Related Biomarkers. [PDF]
Ashfaq Ahmad H +6 more
europepmc +1 more source
Subtype-Specific Aptamer Technologies for Breast Cancer: From Molecular Recognition to Precision Applications. [PDF]
Wu H +6 more
europepmc +1 more source

